IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing

Liquid biopsy testing is a new laboratory-based method that detects tumour mutations in circulating free DNA (cfDNA) derived from minimally invasive blood sampling techniques. Recognising the significance for clinical testing, in 2017, IQN Path provided external quality assessment for liquid biopsy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Virchows Arch
Hauptverfasser: Deans, Zandra C., Butler, Rachel, Cheetham, Melanie, Dequeker, Elisabeth M. C., Fairley, Jennifer A., Fenizia, Francesca, Hall, Jacqueline A., Keppens, Cleo, Normanno, Nicola, Schuuring, Ed, Patton, Simon J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2019
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6581928/
https://ncbi.nlm.nih.gov/pubmed/31028539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00428-019-02571-3
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge